发明名称 Piperidine and piperazine derivatives which function as 5-ht2a receptor antagonists
摘要 Compounds of the formula I in which R1, R2, X, Y and alk are as defined in claim 1, are potent 5-HT2A antagonists and are suitable for the treatment of psychoses, schizophrenia, depression, neurological disorders, memory disorders, Parkinson's disease, amyotrophic lateral sclerosis, Alzheimer's disease, Huntington's disease, eating disorders, such as bulimia, anorexia nervosa, premenstrual syndrome and/or for positively influencing obsessive-compulsive disorder (OCD).
申请公布号 US2003130287(A1) 申请公布日期 2003.07.10
申请号 US20020169399 申请日期 2002.11.05
申请人 ACKERMANN KARL-AUGUST;BOETTCHER HENNING;PRUECHER HELMUT;V. AMSTERDAM CHRISTOPH;SEYFRIED CHRISTOPH;GREINER HARTMUG;BARTOSZYK GERD;HARTING JUERGEN 发明人 ACKERMANN KARL-AUGUST;BOETTCHER HENNING;PRUECHER HELMUT;V. AMSTERDAM CHRISTOPH;SEYFRIED CHRISTOPH;GREINER HARTMUG;BARTOSZYK GERD;HARTING JUERGEN
分类号 C07D215/36;A61K31/444;A61K31/445;A61K31/454;A61K31/47;A61K31/4709;A61K31/496;A61P25/16;A61P25/18;A61P25/24;A61P25/28;C07D209/08;C07D209/40;C07D211/54;C07D213/70;C07D217/02;C07D233/84;C07D271/12;C07D285/14;C07D295/22;C07D295/26;C07D307/91;C07D333/34;C07D333/62;C07D401/04;C07D401/06;C07D401/12;C07D409/06;C07D409/12;C07D409/14;C07D417/12;C07D471/04;C07D513/04;(IPC1-7):A61K31/496;C0741/02;C0743/02 主分类号 C07D215/36
代理机构 代理人
主权项
地址